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Abstract
As a link in the series of studies on tumor-specific immunity, in vitro inhibitory effect of
sensitized isologous lymph-node cells on the proliferation of C3H mammary cancer was studied.
For this purpose tissue culture was conducted with regional lymph-node cells obtained from truly
isologous C3H mouse inoculated with A strain cells derived from C3H mouse mammary cancer
along with A cells, and the following results were obtained. In the case of tissue culture with
those lymph-node cells obtained from the groups of mice 10 days after the inoculation of 5 X
106 A cells, the inhibitory effect on the proliferation of A cells was most marked, followed by
that of those taken on day 14, 7, and 5 decreasing in the order mentioned. In the case with those
regional lymph-node cells obtained from mice which did not have recurrence of tumor 1 week after
extirpation of 2-week old tumor, the inhibitory effect on proliferation of A cells was marked, with
the regional lymph-node cells obtained two weeks after transplantation of 1 × 108 A cells there
could be observed no inhibitory effect at all. This suggests that at a certain stage after implantation
of such regional lymph- node cells there develops a specific anti-tumor activity in the host.
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KLEINl established the concept of tumor specific immunity through his
observation on the primary autochthonous host transplanted with methylcholan-
threne-induced sarcoma. Likewise PREHN2, by using dibenz-(a, h)- anthracene-
induced tumor, and OLDi , using benzpyrene-induced tumor, demonstrated the
existence of tumor-specific antigen. By using MH 134 cells TAKEDA4 reported the
presence of anti-tumor activity of the lymphoid cells from the spleen of F l strain
mice of C3H X dd sensitized with the tumor cells exposed to X-ray by which the
tumor cells had lost the activity of cell division. These tumor-specific antigensin vivo have been demonstrated with isologous or autologous animals inoculated
with viable tumor cells of the same strain after sensitization with previously
treated tumor cells.
For in vitro determination of anti-tumor activity of sensitized lymphoid
cells there are experiments by tissue culture method. HARA6, HANAOKAII and
ROSENAU7 ,8 observed a mutual cell damaging effect between lymphoid cells and
target cells in such tissue culture, and they demonstrated a direct immune reac-
tion between tumor cells and the lymphocytes of the host. However, as they all
used homologous lymphocytes and antigenic cells, their experiments are in
reality executed homotransplantation immunity in vitro.
In the present experiment regional lymph-node cells obtained from C3H
mice sensitized by transplanting mammary cancer derived from the same strain
mouse were made to act on target cells, the mammary cancer cells in tissue
culture. As the result the existence of anti-tumor activity, the presence of tumor
specific antigen, was demonstrated just as in homotransplantation immunity.
Principal findings of the study are described in the following.
261
1
Satoh: In vitro studies on tumor-specific immunity by using C3H mammary
Produced by The Berkeley Electronic Press, 1966
262 K. SATOH
MATERIALS AND METHODS
Animals: C3H (H-2k ) female mice weighing about 20 g whose genotype
was clear were purchased from The Mouse Colony of Okayama University.
They were fed on solid feed. MF of Oriental Yeast Company mixed with some
fresh vegetables and grown to the age of 6.......8 weeks old.
Sensitization of mice: These 63 animals were divided into 4 groups.
To the first group (10 mice) 1 X 108 A strain cells and to the second group (10
mice) 5 X 106 cells were inoculated subcutaneously on the back between the
scapula, and to the third group (15 mice) 5 X 106 of the same A cells were similarly
inoculated. In the case of groups 1 and 2 regional lymph nodes of axilla were
extirpated two weeks after the inoculation, and lymph nodes in group 3 were
from 9 mice which did not have reccurrence of tumor 1 week after extirpation of
2 week-old tumor. Group 4 was further subdivided into 4 subgroups of 7 animals
each. To each of these subgroups 5 X 106 A strain cells were transplanted in the
same manner as with the other groups, 14, 10, 7 and 5 days respectively before
the extirpation of the axillary lymph nodes, and the lymph nodes were extir-
pated from all the subgroups simultaneously on the same day to be used for the
experiment (Fig. 1).
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Fig. 1 Graphic Representation of Transplantation
of C3H Mammary Cancer Cells
Tissue culture cells: A-strain cells are the culture cells originally derived
from mammary cancer that grew spontaneously in C3H female mice and main-
tained in the Pathological Section of Okayama University Cancer Institute and
these cells are first treated with 0.2596 trypsin GKN solution and passed through
the I50-mesh filter, and cultured in the medium of YLE (Earl's balanced salt
solution containing 0.1 96 (w,Iv) yeast extract and o.596C'lv) lactalbumin hydroly-
sate) supplemented with 5096 bovine serum.
Lymph-node cell suspension: From six cancer bearing animals each of
the three groups mentioned above are selected at random and regional lymph
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nodes are extirpated aseptically while under ether anesthesia. These serve as
the materials for sensitized lymph-node cells of each group. From 15 untreated
normal mice axillary lymph nodes are extirpated in a similar manner and these
serve as the materials for control lymph-node cells. These extirpated lymph
nodes are cut into small pieces with ophthalmic scissors and passed through 80-
mesh filter. The filtrate is washed with cold Hank's solution by centrifugation
at 2, 000 rpm for 5 minutes and these washings are repeated three times. After
removal of serum, the rest is suspended in 50% bovine serum plus YLE
medium. Before making suspension in this instance, the countings of viable
cells are taken by counting unstained cells by eosin Y staining9 and those show-
ing over 80 per cent viable cells are used for the experiment.
Culture of lymph-node cells and isologous target cells: For each
group, lymph-node cells, A strain cells, and penicillin are mixed in proportion
of 16 X 10o/ml, 4 X 104/ml, and 100 r/ml, respectively to make the total volume
10 ml. One and half milliliters each of this mixture are pippetted into 6 short
test tubes and the replicate cell culture is carried out at 37°C by the method of
EVANS et al.lo At the intervals of 24 and 48 hours of incubation, 3 test tubes
each are taken out and the medium is removed by gentle decantation. Then
1.5 ml of the crystal violet solution (containing 100 ml distilled water+2.1 g
citric acid +50 mg crystal violet) are added to each of the three test tubes and
the cells are incubated again at 37°C for 30 min. Next, the cells attached to
the wall of test tube are detached gently by a rubber cleaner and by stirring
gently a uniform cell suspension is made. A droplet of this suspension is placed
on Biirker-Tiirk hemocytometer and the cell counts are taken more than six
times for each test tube and the average of three test tubes is taken as the
number of the increase in A strain cells. The distinction between lymph-node
cells and A strain cells is easy because the former are hyperchromatic and have
much smaller nucleus while the latter have larger nucleus.
RESULTS
Two weeks after the subcutaneous inoculation (on the back and in between
the scapula) of A strain cells (derived from mammary cancer of C3H female
mice) there developed tumors of 4. 6 X 3 .5 X 1. 4 cm in average size in the group
1 given 1 X 108 cells and 1. 1 X O. 9 X 0 .6 cm in average in the group 2 inoculated
with 5 X 106 cells. The regional lymph-node cells obtained from the group 1 did
not show any inhibitory effect on A strain cells in culture (Fig. 2); the lymph-
node cells from the group 2 did inhibit the proliferation of A cells; those lymph-
node cells from group 3 obtained one week after the tumor extirpation, exhibited
a marked inhibitory effect (Fig. 3).
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Fig. 2 Curves showing the proliferation of A strain cells in the presence of
regional lymph-node cells obtained 2 weeks after inoculation of 1 X108 A cells
Note: 1 denotes control lymph-node cells+A cells, 2 denotes sensitized lymph-node
cells + A cells, and 3 denotes A cells alone.
For method, refer to the text.
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Fig. 3 Curves showing inhibitory effect of the regionallymph·node cells obtained
2 weeks after transplantation of 5 X 1()6 A cells and the regional lymph-node cells
obtained one week after extirpation of 2-week old tumor, on A strain cells
Note: 1 denotes control lymph-node cells + A strain cells, 2 (5 X106) sensitized
lymph-node cells+A strain cells, 3 (tumor extirpated) sensitized lymph-
node cells + A cells, and 4 A strain cells alone.
For method, refer to the text.
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As for group 4 of the regional lymph-node cells extirpated at various inter-
vals after the inoculation of 5 X 108 cells, those obtained on the tenth day showed
the most marked inhibitory effect on the growth of A cells in culture, and such
inhibitory effect grew weaker in the regional lymph-node cells in the order of
day 14, 7, and 5 after the inoculation (Fig. 4). Looking at the data in this
24
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48
Fig. 4- Curves showing growth-inhibition effect of regional lymph-node cells from
the animal inoculated with A strain cells on the A strain cells in tissue culture
Note: 1 denotes control lymph-node cells+A strain cells, 2 denotes (14 days later)
sensitized lymph-node cells +A cells, 3 denotes (10 days later) sensitized lymph-
node cells+A cells, 4 denotes (7 days later) sensitizod lymph-node cells+A
cells, 5 denotes (5 days later) sensitized lymph-node ceIls+A cells, and 6
denotes A strain cells alone.
For the method, refer to the text.
series of experiments, it is obvious that, compared with the tissue culture of A
strain cells alone, those A strain cells cultured with untreated normal lymph-
node cells invariably tend to accelerate the cell proliferation.
DISCUSSION
HIRSCHll demonstrated that the survival time of the inbred mice sensitized
with spontaneous mammary cancer is prolonged but the animals die of tumor
later. In his experiment with methylcholanthrene-induced sarcoma, KLEIN1 chal-
lenged the autochthonous mice, together with groups of isologous animals, pre-
treated with irradiated sarcoma cells, increasing doses of viable cells from the
original Me-induced sarcoma and found the resistance againt methylcholanthrene-
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induced sarcoma not only in the primary autochthonous host but also in the
isologous mouse. RIGGINS et al. J2 confirmed the immune reaction against spon-
taneous mammary cancer of C3H mice, and demonstrated that this reaction is
weaker than that of methylcholanthrene-induced sarcoma, and the immune
reaction has specificity to immunizing tumor, the extent of which is related to
the inoculating period of tumor cells. In sUl:h a way the existence of tumor
specific antigen in vivo has been made clear. In addition, KLEIN13 demonstrated
that the lymph-node cells of isologous preimmunized mice inhibit the growth of
methylcholanthrene-induced sarcoma in C57BL strain mice.
On the basis of these findings in the present experiments observations of
the mutual reactions between target cells and sensitized lymph-node cells were
carried out in vitro. As the result it has been clarified that in the regional
lymph-node cells obtained from the truly isologous mice to which transplantation
of A strain cells derived from C3H mouse was successful there appears anti-tumor
activity at least in a certain stage after the inoculation.
While there seems to be no report like the present experiment where the
regional lymph-node cells of the host in the case of isograft transplantation show
anti-tumor activity to antigenic tumor cells, ROSENAU7•8 reported that lymph-node
cells obtained from BALB/c strain mouse sensitized with L cells derived from
C3H mouse in the absence of complement adhered specifically to L-cells and these
L-cells were gradually damaged. HARAr., in his mixed cell tissue culture of
lTC-II strain cells (derived from Ehrlich tumor) and the corresponding sensitized
lymph-node cells, found that the growth of lTC-ll cells was inhibited. BRONDZ14
showed that immune mouse lymphocytes exhibit cytotoxic effect on Sal cells.
Everyone of these shows the action behaviors of antigenic cells at homotrans-
plantation, and the action beheviors of sensitized lymphoid cells in vitro seem to
represent the action of the host lymph-node cells against excess histocompatibility
antigen of homologous transplant in vivo.
From the fact that the skin graft transplantation between C3H mouse (used
in this experiment) survived permanently in place and there could be recongnized
no immunological change at alp6, it is assumed that C3H mouse is isologous as
far as histocompatibility gene is concerned. Consequently, it might be fairly
reasonable to assume that the anti-tumor activity by the regional lymph node to
·mammary cancer derived from isologous mouse is a reflection of immunological
reaction in vitro of lymph-node cells to mammary cancer cell specific antigen
other than histocompatibility gene itself.
Those regional lymph-node cells from the group extirpated of tumor show
much stronger inhibitory action than the tumor bearing group, and those lymph-
node cells from the group of mice on the threshold of death from tumors do not
show any inhibitory action.
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This fact seems to indicate that the lymph-node cells in the terminal stage
of cancer become paralytic because of an enormous amount of antigens from
tumor cells and react as a sort of enhancement factor to tumor. In either case,
these two factors seem to be involved in the unlimited growth of cancer.
SUMMARY
As a link in the series of studies on tumor-specific immunity, in vitro inhi-
bitory effect of sensitized isologous lymph-node cells on the proliferation of C3H
mammary cancer was studied. For this purpose tissue culture was conducted
with regional lymph-node cells obtained from truly isologous C3H mouse inocu-
lated with A strain cells derived from C3H mouse mammary cancer along with
A cells, and the following results were obtained.
In the case of tissue culture with those lymph-node cells obtained from the
groups of mice 10 days after the inoculation of 5 X 106 A cells, the inhibitory
effect on the proliferation of A cells was most'marked, followed by that of those
taken on day 14, 7, and 5 decreasing in the order mentioned.
In the case with those regional lymph-node cells obtained from mice which
did not have recurrence of tumor 1 week after extirpation of 2-week old tumor,
the inhibitory effect on proliferation of A cells was marked, with the regional
lymph-node cells obtained two weeks after transplantation of 1 X 108 A cells
there could be observed no inhibitory effect at all. This suggests that at a
certain stage after implantation of such regional lymph-node cells there develops
a specific anti-tumor activity in the host.
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